SAN

88.8

-1.15%↓

SRT3

232.4

-0.56%↓

BIM

117.4

-0.25%↓

ORNBV.FI

54.7

-1.35%↓

GXI

61.8

-0.72%↓

SAN

88.8

-1.15%↓

SRT3

232.4

-0.56%↓

BIM

117.4

-0.25%↓

ORNBV.FI

54.7

-1.35%↓

GXI

61.8

-0.72%↓

SAN

88.8

-1.15%↓

SRT3

232.4

-0.56%↓

BIM

117.4

-0.25%↓

ORNBV.FI

54.7

-1.35%↓

GXI

61.8

-0.72%↓

SAN

88.8

-1.15%↓

SRT3

232.4

-0.56%↓

BIM

117.4

-0.25%↓

ORNBV.FI

54.7

-1.35%↓

GXI

61.8

-0.72%↓

SAN

88.8

-1.15%↓

SRT3

232.4

-0.56%↓

BIM

117.4

-0.25%↓

ORNBV.FI

54.7

-1.35%↓

GXI

61.8

-0.72%↓

Search

Pharming Group NV

Deschisă

0.833 -4.8

Rezumat

Modificarea prețului

24h

Curent

Minim

0.833

Maxim

0.88

Indicatori cheie

By Trading Economics

Venit

4.3M

3.4M

Vânzări

18M

93M

EPS

-0.02

Marjă de profit

3.657

Angajați

404

EBITDA

1.9M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+129.72% upside

Dividende

By Dow Jones

Următoarele câștiguri

31 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

119M

609M

Deschiderea anterioară

5.63

Închiderea anterioară

0.833

Pharming Group NV Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 mai 2025, 23:20 UTC

Câștiguri

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13 mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13 mai 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13 mai 2025, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13 mai 2025, 23:24 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

13 mai 2025, 23:24 UTC

Market Talk
Câștiguri

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13 mai 2025, 22:58 UTC

Câștiguri

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mai 2025, 22:58 UTC

Câștiguri

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mai 2025, 22:58 UTC

Câștiguri

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13 mai 2025, 22:58 UTC

Câștiguri

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13 mai 2025, 22:38 UTC

Câștiguri

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13 mai 2025, 22:38 UTC

Câștiguri

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13 mai 2025, 22:37 UTC

Câștiguri

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13 mai 2025, 22:36 UTC

Câștiguri

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13 mai 2025, 22:35 UTC

Câștiguri

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13 mai 2025, 22:34 UTC

Câștiguri

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13 mai 2025, 22:33 UTC

Câștiguri

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13 mai 2025, 22:33 UTC

Câștiguri

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13 mai 2025, 22:33 UTC

Câștiguri

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13 mai 2025, 22:30 UTC

Câștiguri

Aristocrat Interim Dividend 44 Australian Cents/Share

13 mai 2025, 22:30 UTC

Câștiguri

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13 mai 2025, 22:29 UTC

Câștiguri

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13 mai 2025, 22:28 UTC

Câștiguri

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13 mai 2025, 21:15 UTC

Câștiguri

Nu Holdings 1Q Rev $3.2B >NU

13 mai 2025, 21:03 UTC

Top știri

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13 mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

13 mai 2025, 20:32 UTC

Câștiguri

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mai 2025, 20:31 UTC

Câștiguri

Alcon 1Q Sales $2.45B >ALC.EB

13 mai 2025, 20:30 UTC

Câștiguri

Alcon 1Q Rev $2.47B >ALC.EB

13 mai 2025, 20:30 UTC

Câștiguri

Alcon 1Q EPS 70c >ALC.EB

Comparație

Modificare preț

Pharming Group NV Așteptări

Obiectiv de preț

By TipRanks

129.72% sus

Prognoză pe 12 luni

Medie 1.999 EUR  129.72%

Maxim 2 EUR

Minim 2 EUR

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPharming Group NV - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.